|
1
|
Abdullah M, Humayun A, Imran M, Bashir MA
and Malik AA: A bibliometric analysis of global research
performance on tuberculosis (2011–2020): Time for a global approach
to support high-burden countries. J Family Community Med.
29:117–124. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li XX, Zhang H, Jiang SW, Liu XQ, Fang Q,
Li J, Li X and Wang LX: Geographical distribution regarding the
prevalence rates of pulmonary tuberculosis in China in 2010.
Zhonghua Liu Xing Bing Xue Za Zhi. 34:980–984. 2013.(In Chinese).
PubMed/NCBI
|
|
3
|
Wubuli A, Xue F, Jiang D, Yao X, Upur H
and Wushouer Q: Socio-demographic predictors and distribution of
pulmonary tuberculosis (TB) in Xinjiang, China: A spatial analysis.
PLoS One. 10:e01440102015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang L, Zhang H, Ruan Y, Chin DP, Xia Y,
Cheng S, Chen M, Zhao Y, Jiang S, Du X, et al: Tuberculosis
prevalence in China, 1990–2010; a longitudinal analysis of national
survey data. Lancet. 383:2057–2064. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He X, Cao M, Mahapatra T, Du X, Mahapatra
S, Li Q, Feng L, Tang S, Zhao Z, Liu J and Tang W: Burden of
tuberculosis in Xinjiang between 2011 and 2015: A surveillance
data-based study. PLoS One. 12:e01875922017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anilkumar U and Prehn JHM: Anti-apoptotic
BCL-2 family proteins in acute neural injury. Front Cell Neurosci.
8:2812014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Behar SM, Divangahi M and Remold HG:
Evasion of innate immunity by Mycobacterium tuberculosis: Is
death an exit strategy? Nat Rev Microbiol. 8:668–674. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Deretic V and Wang F: Autophagy is part of
the answer to tuberculosis. Nat Microbiol. 8:762–763. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arnett E and Schlesinger LS: Live and let
die: TB control by enhancing apoptosis. Immunity. 54:1625–1627.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Häcker G: Apoptosis in infection. Microbes
Infect. 20:552–559. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ashida H, Mimuro H, Ogawa M, Kobayashi T,
Sanada T, Kim M and Sasakawa C: Cell death and infection: A
double-edged sword for host and pathogen survival. J Cell Biol.
195:931–942. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hirsch CS, Johnson JL, Okwera A, Kanost
RA, Wu M, Peters P, Muhumuza M, Mayanja-Kizza H, Mugerwa RD,
Mugyenyi P, et al: Mechanisms of apoptosis of T-cells in human
tuberculosis. J Clin Immunol. 25:353–364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pagán AJ and Ramakrishnan L: Immunity and
immunopathology in the tuberculous granuloma. Cold Spring Harb
Perspect Med. 5:a0184992014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Enserink JM and Kolodner RD: An overview
of Cdk1-controlled targets and processes. Cell Div. 5:112010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morgan DO: Cyclin-dependent kinases:
Engines, clocks, and microprocessors. Annu Rev Cell Dev Biol.
13:261–291. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang R, Gao S, Han Y, Ning H, Zhou Y,
Guan H, Liu X, Yan S and Zhou PK: BECN1 promotes radiation-induced
G2/M arrest through regulation CDK1 activity: A potential role for
autophagy in G2/M checkpoint. Cell Death Discov. 6:702020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang S, Xiao J, Wu J, Liu J, Feng X, Yang
C, Xiang D and Luo S: Tizoxanide promotes apoptosis in glioblastoma
by inhibiting CDK1 activity. Front Pharmacol. 13:8955732022.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Q, Chen L, Gao M, Wang S, Meng L and
Guo L: Molecular docking and in vitro experiments verified that
kaempferol induced apoptosis and inhibited human HepG2 cell
proliferation by targeting BAX, CDK1, and JUN. Mol Cell Biochem.
478:767–780. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu G, Yan X, Hu Z, Zheng L, Ding K, Zhang
Y, Qing Y, Liu T, Cheng L and Shi Z: Glucocappasalin induces
G2/M-phase arrest, apoptosis, and autophagy pathways by targeting
CDK1 and PLK1 in cervical carcinoma cells. Front Pharmacol.
12:6711382021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang YJ, Luo S and Xu ZL: Effects of
miR-490-5p targeting CDK1 on proliferation and apoptosis of colon
cancer cells via ERK signaling pathway. Eur Rev Med Pharmacol Sci.
26:2049–2056. 2022.PubMed/NCBI
|
|
22
|
Tong Y, Huang Y, Zhang Y, Zeng X, Yan M,
Xia Z and Lai D: DPP3/CDK1 contributes to the progression of
colorectal cancer through regulating cell proliferation, cell
apoptosis, and cell migration. Cell Death Dis. 12:5292021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Y, Fan Y, Zhao Z, Zhang X, Tucker K,
Staley A, Suo H, Sun W, Shen X, Deng B, et al: Inhibition of CDK1
by RO-3306 exhibits anti-tumorigenic effects in ovarian cancer
cells and a transgenic mouse model of ovarian cancer. Int J Mol
Sci. 24:123752023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ozaki T and Nakagawara A: Role of p53 in
cell death and human cancers. Cancers (Basel). 3:994–1013. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen J: The cell-cycle arrest and
apoptotic functions of p53 in tumor initiation and progression.
Cold Spring Harb Perspect Med. 6:a0261042016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng SJ, Lamhamedi-Cherradi SE, Wang P,
Xu L and Chen YH: Tumor suppressor p53 inhibits autoimmune
inflammation and macrophage function. Diabetes. 54:1423–1428. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fischer M: Census and evaluation of p53
target genes. Oncogene. 36:3943–3956. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lim YJ, Lee J, Choi JA, Cho SN, Son SH,
Kwon SJ, Son JW and Song CH: M1 macrophage dependent-p53 regulates
the intracellular survival of mycobacteria. Apoptosis. 25:42–55.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gong X, Li Y, Yao L, Aynur M, Liu N, Wang
L and Wang J: Preliminary study on genotype of Mycobacterium
tuberculosis in some areas of Xinjiang by the multiple locus
VNTR analysis. Chin J Lung Dis (Electronic Edition). 10:304–308.
2017.(In Chinese).
|
|
30
|
Chinese Society of Tuberculosis and
Chinese Medical Association, . Guidelines for the Diagnosis and
Treatment of Pulmonary Tuberculosis. Chin J Tuberc Respir Dis.
24:70–74. 2001.(In Chinese).
|
|
31
|
Kim D, Paggi JM, Park C, Bennett C and
Salzberg SL: Graph-based genome alignment and genotyping with
HISAT2 and HISAT-genotype. Nat Biotechnol. 37:907–915. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ghosh S and Chan CKK: Analysis of RNA-seq
data using tophat and cufflinks. Methods Mol Biol. 1374:339–361.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Anders S, Pyl PT and Huber W: HTSeq-a
Python framework to work with high-throughput sequencing data.
Bioinformatics. 31:166–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bader GD and Hogue CWV: An automated
method for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang J, Mi L, Wang Y, Liu P, Liang H,
Huang Y, Lv B and Yuan L: Genotypes and drug susceptibility of
Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang
Province, China. BMC Res Notes. 5:3092012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yuan L, Mi L, Li Y, Zhang H, Zheng F and
Li Z: Genotypic characteristics of Mycobacterium
tuberculosis circulating in Xinjiang, China. Infect Dis (Lond).
48:108–115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rao KR, Ahmed N, Srinivas S, Sechi LA and
Hasnain SE: Rapid identification of Mycobacterium
tuberculosis Beijing genotypes on the basis of the
mycobacterial interspersed repetitive unit locus 26 signature. J
Clin Microbiol. 44:274–277. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Long R, Jones R, Talbot J, Mayers I,
Barrie J, Hoskinson M and Light B: Inhaled nitric oxide treatment
of patients with pulmonary tuberculosis evidenced by positive
sputum smears. Antimicrob Agents Chemother. 49:1209–1212. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Butala B, Busada M and Cormican D:
Malignant hyperthermia: Review of diagnosis and treatment during
cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc
Anesth. 32:2771–2779. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fatima N, Upadhyay T, Ahmad F, Arshad M,
Kamal MA, Sharma D and Sharma R: Particulate β-glucan activates
early and delayed phagosomal maturation and autophagy within
macrophage in a NOX-2 dependent manner. Life Sci. 266:1188512021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Majeed M, Perskvist N, Ernst JD, Orselius
K and Stendahl O: Roles of calcium and annexins in phagocytosis and
elimination of an attenuated strain of Mycobacterium
tuberculosis in human neutrophils. Microb Pathog. 24:309–320.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nasir N and Kisker C: Mechanistic insights
into the enzymatic activity and inhibition of the replicative
polymerase exonuclease domain from Mycobacterium
tuberculosis. DNA Repair (Amst). 74:17–25. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Parveen N, Varman R, Nair S, Das G, Ghosh
S and Mukhopadhyay S: Endocytosis of Mycobacterium
tuberculosis heat shock protein 60 is required to induce
interleukin-10 production in macrophages. J Biol Chem.
288:24956–24971. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sachdeva K, Goel M and Sundaramurthy V:
Heterogeneity in the endocytic capacity of individual macrophage in
a population determines its subsequent phagocytosis, infectivity
and subcellular trafficking. Traffic. 21:522–533. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Moreira-Teixeira L, Stimpson PJ,
Stavropoulos E, Hadebe S, Chakravarty P, Ioannou M, Aramburu IV,
Herbert E, Priestnall SL, Suarez-Bonnet A, et al: Type I IFN
exacerbates disease in tuberculosis-susceptible mice by inducing
neutrophil-mediated lung inflammation and NETosis. Nat Commun.
11:55662020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kroon EE, Correa-Macedo W, Evans R, Seeger
A, Engelbrecht L, Kriel JA, Loos B, Okugbeni N, Orlova M, Cassart
P, et al: Neutrophil extracellular trap formation and gene programs
distinguish TST/IGRA sensitization outcomes among Mycobacterium
tuberculosis exposed persons living with HIV. PLoS Genet.
19:e10108882023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dang G, Cui Y, Wang L, Li T, Cui Z, Song
N, Chen L, Pang H and Liu S: Extracellular sphingomyelinase Rv0888
of Mycobacterium tuberculosis contributes to pathological
lung injury of mycobacterium smegmatis in mice via inducing
formation of neutrophil extracellular traps. Front Immunol.
9:6772018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bobak CA, Abhimanyu Natarajan H, Gandhi T,
Grimm SL, Nishiguchi T, Koster K, Longlax SC, Dlamini Q, Kahari J,
et al: Increased DNA methylation, cellular senescence and premature
epigenetic aging in guinea pigs and humans with tuberculosis. Aging
(Albany NY). 14:2174–2193. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Parandhaman DK and Narayanan S: Cell death
paradigms in the pathogenesis of Mycobacterium tuberculosis
infection. Front Cell Infect Microbiol. 4:312014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li S, Wang D, Wei P, Liu R, Guo J, Yang B,
Zhang H, Lu J, Gao M and Pang Y: Elevated natural killer
cell-mediated cytotoxicity is associated with cavity formation in
pulmonary tuberculosis patients. J Immunol Res. 2021:79259032021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liang S, Song Z, Wu Y, Gao Y, Gao M, Liu
F, Wang F and Zhang Y: MicroRNA-27b modulates inflammatory response
and apoptosis during Mycobacterium tuberculosis infection. J
Immunol. 200:3506–3518. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Houghton J, Townsend C, Williams AR,
Rodgers A, Rand L, Walker KB, Böttger EC, Springer B and Davis EO:
Important role for Mycobacterium tuberculosis UvrD1 in
pathogenesis and persistence apart from its function in nucleotide
excision repair. J Bacteriol. 194:2916–2923. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jin M, Li J, Hu R, Xu B, Huang G, Huang W,
Chen B, He J and Cao Y: Cyclin A2/cyclin-dependent kinase
1-dependent phosphorylation of Top2a is required for S phase entry
during retinal development in zebrafish. J Genet Genomics.
48:63–74. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Thorenoor N, Faltejskova-Vychytilova P,
Hombach S, Mlcochova J, Kretz M, Svoboda M and Slaby O: Long
non-coding RNA ZFAS1 interacts with CDK1 and is involved in
p53-dependent cell cycle control and apoptosis in colorectal
cancer. Oncotarget. 7:622–637. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fogal V, Hsieh JK, Royer C, Zhong S and Lu
X: Cell cycle-dependent nuclear retention of p53 by E2F1 requires
phosphorylation of p53 at Ser315. EMBO J. 24:2768–2782. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Aida S, Hozumi M, Ichikawa D, Iida K,
Yonemura Y, Tabata N, Yamada T, Matsushita M, Sugai T, Yanagawa H
and Hattori Y: A novel phenylphthalimide derivative, pegylated
TC11, improves pharmacokinetic properties and induces apoptosis of
high-risk myeloma cells via G2/M cell-cycle arrest. Biochem Biophys
Res Commun. 493:514–520. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ichikawa D, Nakamura M, Murota W, Osawa S,
Matsushita M, Yanagawa H and Hattori Y: A phenylphthalimide
derivative, TC11, induces apoptosis by degrading MCL1 in multiple
myeloma cells. Biochem Biophys Res Commun. 521:252–258. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Shiheido H, Terada F, Tabata N, Hayakawa
I, Matsumura N, Takashima H, Ogawa Y, Du W, Yamada T, Shoji M, et
al: A phthalimide derivative that inhibits centrosomal clustering
is effective on multiple myeloma. PLoS One. 7:e388782012.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Reid M, Agbassi YJP, Arinaminpathy N,
Bercasio A, Bhargava A, Bhargava M, Bloom A, Cattamanchi A,
Chaisson R, Chin D, et al: Scientific advances and the end of
tuberculosis: A report from the lancet commission on tuberculosis.
Lancet. 402:1473–1498. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Chandra P, Grigsby SJ and Philips JA:
Immune evasion and provocation by Mycobacterium
tuberculosis. Nat Rev Microbiol. 20:750–766. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Jin C, Wu X, Dong C, Li F, Fan L, Xiong S
and Dong Y: EspR promotes mycobacteria survival in macrophages by
inhibiting MyD88 mediated inflammation and apoptosis. Tuberculosis
(Edinb). 116:22–31. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Li F, Feng L, Jin C, Wu X, Fan L, Xiong S
and Dong Y: LpqT improves mycobacteria survival in macrophages by
inhibiting TLR2 mediated inflammatory cytokine expression and cell
apoptosis. Tuberculosis (Edinb). 111:57–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Feng L, Hu J, Zhang W, Dong Y, Xiong S and
Dong C: RELL1 inhibits autophagy pathway and regulates
Mycobacterium tuberculosis survival in macrophages.
Tuberculosis (Edinb). 120:1019002020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Dai X, Zhou L, He X, Hua J, Chen L and Lu
Y: Identification of apoptosis-related gene signatures as potential
biomarkers for differentiating active from latent tuberculosis via
bioinformatics analysis. Front Cell Infect Microbiol.
14:12854932024. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lim S and Kaldis P: Cdks, cyclins and
CKIs: Roles beyond cell cycle regulation. Development.
140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Satyanarayana A and Kaldis P: Mammalian
cell-cycle regulation: Several Cdks, numerous cyclins and diverse
compensatory mechanisms. Oncogene. 28:2925–2939. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Barnum KJ and O'Connell MJ: Cell cycle
regulation by checkpoints. Methods Mol Biol. 1170:29–40. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Risal S, Adhikari D and Liu K: Animal
models for studying the in vivo functions of cell cycle CDKs.
Methods Mol Biol. 1336:155–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhu Y, Li K, Zhang J, Wang L, Sheng L and
Yan L: Inhibition of CDK1 reverses the resistance of 5-Fu in
colorectal cancer. Cancer Manag Res. 12:11271–11283. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Huang Z, Shen G and Gao J: CDK1 promotes
the stemness of lung cancer cells through interacting with Sox2.
Clin Transl Oncol. 23:1743–1751. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Dai Y, Hu S, Bai S, Li J, Yang N, Zhai P,
Zhao B, Chen Y and Wu X: CDK1 promotes the proliferation of
melanocytes in Rex rabbits. Genes Genomics. 44:1191–1199. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chen Q, Xu L, Lu C, Xue Y, Gong X, Shi Y,
Wang C and Yu L: Prognostic significance of CDK1 expression in
diffuse large B-Cell lymphoma. BMC Cancer. 25:202025. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Piao J, Zhu L, Sun J, Li N, Dong B, Yang Y
and Chen L: High expression of CDK1 and BUB1 predicts poor
prognosis of pancreatic ductal adenocarcinoma. Gene. 701:15–22.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Malumbres M: Cyclin-dependent kinases.
Genome Biol. 15:1222014. View
Article : Google Scholar : PubMed/NCBI
|
|
76
|
Kang X, Chen H, Zhou Z, Tu S, Cui B, Li Y,
Dong S, Zhang Q and Xu Y: Targeting cyclin-dependent kinase 1
induces apoptosis and cell cycle arrest of activated hepatic
stellate cells. Adv Biol (Weinh). 8:e23004032024. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Hager KM and Gu W: Understanding the
non-canonical pathways involved in p53-mediated tumor suppression.
Carcinogenesis. 35:740–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Kang R, Kroemer G and Tang D: The tumor
suppressor protein p53 and the ferroptosis network. Free Radic Biol
Med. 133:162–168. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kruiswijk F, Labuschagne CF and Vousden
KH: p53 in survival, death and metabolic health: A lifeguard with a
licence to kill. Nat Rev Mol Cell Biol. 16:393–405. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Bao J, He Y, Yang C, Lu N, Li A, Gao S,
Hosyanto FF, Tang J, Si J, Tang X, et al: Inhibition of
mycobacteria proliferation in macrophages by low cisplatin
concentration through phosphorylated p53-related apoptosis pathway.
PLoS One. 18:e02811702023. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yuan Y, Zhang X, Du K, Zhu X, Chang S,
Chen Y, Xu Y, Sun J, Luo X, Deng S, et al: Circ_CEA promotes the
interaction between the p53 and cyclin-dependent kinases 1 as a
scaffold to inhibit the apoptosis of gastric cancer. Cell Death
Dis. 13:8272022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Klingler K, Tchou-Wong KM, Brändli O,
Aston C, Kim R, Chi C and Rom WN: Effects of mycobacteria on
regulation of apoptosis in mononuclear phagocytes. Infect Immun.
65:5272–5278. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Danelishvili L, McGarvey J, Li YJ and
Bermudez LE: Mycobacterium tuberculosis infection causes
different levels of apoptosis and necrosis in human macrophages and
alveolar epithelial cells. Cell Microbiol. 5:649–660. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ciaramella A, Cavone A, Santucci MB, Garg
SK, Sanarico N, Bocchino M, Galati D, Martino A, Auricchio G,
D'Orazio M, et al: Induction of apoptosis and release of
interleukin-1 beta by cell wall-associated 19-kDa lipoprotein
during the course of mycobacterial infection. J Infect Dis.
190:1167–1176. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
85
|
Arcila ML, Sánchez MD, Ortiz B, Barrera
LF, García LF and Rojas M: Activation of apoptosis, but not
necrosis, during Mycobacterium tuberculosis infection
correlated with decreased bacterial growth: Role of TNF-alpha,
IL-10, caspases and phospholipase A2. Cell Immunol. 249:80–93.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Lee KI, Choi S, Choi HG, Kebede SG, Dang
TB, Back YW, Park HS and Kim HJ: Recombinant Rv3261 protein of
Mycobacterium tuberculosis induces apoptosis through a
mitochondrion-dependent pathway in macrophages and inhibits
intracellular bacterial growth. Cell Immunol. 354:1041452020.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
MedhaPriyanka Bhatt P, Sharma S and Sharma
M: Role of C-terminal domain of Mycobacterium tuberculosis
PE6 (Rv0335c) protein in host mitochondrial stress and macrophage
apoptosis. Apoptosis. 28:136–165. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zychlinsky A: Programmed cell death in
infectious diseases. Trends Microbiol. 1:114–117. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Stenger S, Mazzaccaro RJ, Uyemura K, Cho
S, Barnes PF, Rosat JP, Sette A, Brenner MB, Porcelli SA, Bloom BR
and Modlin RL: Differential effects of cytolytic T cell subsets on
intracellular infection. Science. 276:1684–1687. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kelly DM, ten Bokum AM, O'Leary SM,
O'Sullivan MP and Keane J: Bystander macrophage apoptosis after
Mycobacterium tuberculosis H37Ra infection. Infect Immun.
76:351–360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Lee J, Remold HG, Ieong MH and Kornfeld H:
Macrophage apoptosis in response to high intracellular burden of
Mycobacterium tuberculosis is mediated by a novel
caspase-independent pathway. J Immunol. 176:4267–4274. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Gan H, Lee J, Ren F, Chen M, Kornfeld H
and Remold HG: Mycobacterium tuberculosis blocks
crosslinking of annexin-1 and apoptotic envelope formation on
infected macrophages to maintain virulence. Nat Immunol.
9:1189–1197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Chen M, Gan H and Remold HG: A mechanism
of virulence: Virulent Mycobacterium tuberculosis strain
H37Rv, but not attenuated H37Ra, causes significant mitochondrial
inner membrane disruption in macrophages leading to necrosis. J
Immunol. 176:3707–3716. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Afriyie-Asante A, Dabla A, Dagenais A,
Berton S, Smyth R and Sun J: Mycobacterium tuberculosis
exploits focal adhesion kinase to induce necrotic cell death and
inhibit reactive oxygen species production. Front Immunol.
12:7423702021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Mohareer K, Medikonda J, Vadankula GR and
Banerjee S: Mycobacterial control of host mitochondria:
Bioenergetic and metabolic changes shaping cell fate and infection
outcome. Front Cell Infect Microbiol. 10:4572020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Behar SM, Martin CJ, Booty MG, Nishimura
T, Zhao X, Gan HX, Divangahi M and Remold HG: Apoptosis is an
innate defense function of macrophages against Mycobacterium
tuberculosis. Mucosal Immunol. 4:279–287. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Dallenga T, Repnik U, Corleis B, Eich J,
Reimer R, Griffiths GW and Schaible UE: M. tuberculosis-induced
necrosis of infected neutrophils promotes bacterial growth
following phagocytosis by macrophages. Cell Host Microbe.
22:519–530.e3. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Toossi Z: The inflammatory response in
Mycobacterium tuberculosis infection. Arch Immunol Ther Exp
(Warsz). 48:513–519. 2000.PubMed/NCBI
|
|
99
|
Amaral EP, Costa DL, Namasivayam S, Riteau
N, Kamenyeva O, Mittereder L, Mayer-Barber KD, Andrade BB and Sher
A: A major role for ferroptosis in Mycobacterium
tuberculosis-induced cell death and tissue necrosis. J Exp Med.
216:556–570. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Su H, Zhu S, Zhu L, Huang W, Wang H, Zhang
Z and Xu Y: Recombinant lipoprotein Rv1016c derived from
Mycobacterium tuberculosis is a TLR-2 ligand that induces
macrophages apoptosis and inhibits MHC II antigen processing. Front
Cell Infect Microbiol. 6:1472016. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Schaible UE, Winau F, Sieling PA, Fischer
K, Collins HL, Hagens K, Modlin RL, Brinkmann V and Kaufmann SH:
Apoptosis facilitates antigen presentation to T lymphocytes through
MHC-I and CD1 in tuberculosis. Nat Med. 9:1039–1046. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Velmurugan K, Chen B, Miller JL, Azogue S,
Gurses S, Hsu T, Glickman M, Jacobs WR Jr, Porcelli SA and Briken
V: Mycobacterium tuberculosis nuoG is a virulence gene that
inhibits apoptosis of infected host cells. PLoS Pathog. 3:e1102007.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Nisa A, Kipper FC, Panigrahy D, Tiwari S,
Kupz A and Subbian S: Different modalities of host cell death and
their impact on Mycobacterium tuberculosis infection. Am J
Physiol Cell Physiol. 323:C1444–C1474. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Kornfeld H, Mancino G and Colizzi V: The
role of macrophage cell death in tuberculosis. Cell Death Differ.
6:71–78. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Lammas DA, Stober C, Harvey CJ, Kendrick
N, Panchalingam S and Kumararatne DS: ATP-induced killing of
mycobacteria by human macrophages is mediated by purinergic
P2Z(P2X7) receptors. Immunity. 7:433–444. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Kusner DJ and Adams J: ATP-induced killing
of virulent Mycobacterium tuberculosis within human
macrophages requires phospholipase D. J Immunol. 164:379–388. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Laochumroonvorapong P, Paul S, Elkon KB
and Kaplan G: H2O2 induces monocyte apoptosis and reduces viability
of Mycobacterium avium-M. intracellulare within cultured human
monocytes. Infect Immun. 64:452–459. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Fratazzi C, Arbeit RD, Carini C and Remold
HG: Programmed cell death of Mycobacterium avium serovar 4-infected
human macrophages prevents the mycobacteria from spreading and
induces mycobacterial growth inhibition by freshly added,
uninfected macrophages. J Immunol. 158:4320–4327. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Aliprantis AO, Yang RB, Mark MR, Suggett
S, Devaux B, Radolf JD, Klimpel GR, Godowski P and Zychlinsky A:
Cell activation and apoptosis by bacterial lipoproteins through
toll-like receptor-2. Science. 285:736–739. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Brightbill HD, Libraty DH, Krutzik SR,
Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy
SE, Smale ST, et al: Host defense mechanisms triggered by microbial
lipoproteins through toll-like receptors. Science. 285:732–736.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Ren Y and Savill J: Apoptosis: The
importance of being eaten. Cell Death Differ. 5:563–568. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Martin CJ, Peters KN and Behar SM:
Macrophages clean up: Efferocytosis and microbial control. Curr
Opin Microbiol. 17:17–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Idh J, Mekonnen M, Abate E, Wedajo W,
Werngren J, Ängeby K, Lerm M, Elias D, Sundqvist T, Aseffa A, et
al: Resistance to first-line anti-TB drugs is associated with
reduced nitric oxide susceptibility in Mycobacterium
tuberculosis. PLoS One. 7:e398912012. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Flesch IE and Kaufmann SH: Mechanisms
involved in mycobacterial growth inhibition by gamma
interferon-activated bone marrow macrophages: Role of reactive
nitrogen intermediates. Infect Immun. 59:3213–3218. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Korver AJ: Amputees in a hospital of the
international committee of the red cross. Injury. 24:607–609. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
MacMicking JD, North RJ, LaCourse R,
Mudgett JS, Shah SK and Nathan CF: Identification of nitric oxide
synthase as a protective locus against tuberculosis. Proc Natl Acad
Sci USA. 94:5243–5248. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Denis M: Interferon-gamma-treated murine
macrophages inhibit growth of tubercle bacilli via the generation
of reactive nitrogen intermediates. Cell Immunol. 132:150–157.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Chan J, Xing Y, Magliozzo RS and Bloom BR:
Killing of virulent Mycobacterium tuberculosis by reactive
nitrogen intermediates produced by activated murine macrophages. J
Exp Med. 175:1111–1122. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Jamaati H, Mortaz E, Pajouhi Z, Folkerts
G, Movassaghi M, Moloudizargari M, Adcock IM and Garssen J: Nitric
oxide in the pathogenesis and treatment of tuberculosis. Front
Microbiol. 8:20082017. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Peteroy-Kelly M, Venketaraman V and
Connell ND: Effects of Mycobacterium bovis BCG infection on
regulation of L-arginine uptake and synthesis of reactive nitrogen
intermediates in J774.1 murine macrophages. Infect Immun.
69:5823–5831. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Arias M, Rojas M, Zabaleta J, Rodríguez
JI, París SC, Barrera LF and García LF: Inhibition of virulent
Mycobacterium tuberculosis by Bcg(r) and Bcg(s) macrophages
correlates with nitric oxide production. J Infect Dis.
176:1552–1558. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
122
|
Dlugovitzky D, Bay ML, Rateni L, Vietti L,
Farroni MA and Bottasso OA: Influence of disease severity on
nitrite and cytokine production by peripheral blood mononuclear
cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin
Exp Immunol. 122:343–349. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Ernst WA, Thoma-Uszynski S, Teitelbaum R,
Ko C, Hanson DA, Clayberger C, Krensky AM, Leippe M, Bloom BR, Ganz
T and Modlin RL: Granulysin, a T cell product, kills bacteria by
altering membrane permeability. J Immunol. 165:7102–7108. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Chan ED, Morris KR, Belisle JT, Hill P,
Remigio LK, Brennan PJ and Riches DW: Induction of inducible nitric
oxide synthase-NO* by lipoarabinomannan of Mycobacterium
tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB
signaling pathways. Infect Immun. 69:2001–2010. 2001. View Article : Google Scholar : PubMed/NCBI
|
